Pages that link to "Q208376"
Jump to navigation
Jump to search
The following pages link to positron emission tomography (Q208376):
Displayed 50 items.
- multiple sclerosis (Q8277) (← links)
- Parkinson's disease (Q11085) (← links)
- prostate cancer (Q181257) (← links)
- colorectal cancer (Q188874) (← links)
- pancreatic cancer (Q212961) (← links)
- esophageal cancer (Q372701) (← links)
- GE Healthcare (Q1152374) (← links)
- PET-CT (Q3488638) (← links)
- Brain positron emission tomography (Q4955834) (← links)
- (Q6101320) (redirect page) (← links)
- PET-MRI (Q7119021) (← links)
- Turku PET Centre (Q18662171) (← links)
- Category:Positron emission tomography (Q20927303) (← links)
- Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography (Q21146623) (← links)
- [11C]ME@HAPTHI (Q21848540) (← links)
- In vivo molecular imaging of experimental joint inflammation by combined (18)F-FDG positron emission tomography and computed tomography. (Q22000844) (← links)
- Positron emission tomography imaging in multiple sclerosis-current status and future applications (Q22242393) (← links)
- PetScan (Q23665536) (← links)
- The predictive power of brain mRNA mappings for in vivo protein density: a positron emission tomography correlation study (Q23992160) (← links)
- 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma (Q24186888) (← links)
- Positron emission tomography (PET) for the detection of vascular graft infections (Q24188131) (← links)
- Positron emission tomography (PET)-adapted therapy for Hodgkin lymphoma patients (Q24202622) (← links)
- False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review (Q24288664) (← links)
- Obsessive compulsive disorder networks: positron emission tomography and neuropsychology provide new insights (Q24288703) (← links)
- Positron emission tomography with oxygen-15 of stunned myocardium caused by coronary artery vasospasm after recovery (Q24563261) (← links)
- Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers (Q24563637) (← links)
- Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine (Q24564984) (← links)
- A molecularly engineered split reporter for imaging protein-protein interactions with positron emission tomography (Q24595263) (← links)
- Positron emission tomography imaging of prostate cancer (Q24596241) (← links)
- Nonhuman primate positron emission tomography neuroimaging in drug abuse research (Q24607038) (← links)
- Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons (Q24608685) (← links)
- Occupancy of dopamine D₂ and D₃ and serotonin 5-HT₁A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography (Q24630426) (← links)
- A review and synthesis of the first 20 years of PET and fMRI studies of heard speech, spoken language and reading (Q24631232) (← links)
- Synthesis, structure-affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography (Q24633892) (← links)
- The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders (Q24641816) (← links)
- Synthesis and in vitro and in vivo evaluation of 18F-labeled positron emission tomography (PET) ligands for imaging the vesicular acetylcholine transporter (Q24650088) (← links)
- Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem (Q24652621) (← links)
- [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor (Q24680848) (← links)
- Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer (Q24802651) (← links)
- Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) (Q24805277) (← links)
- Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD (Q24805375) (← links)
- Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography (Q24810786) (← links)
- Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography (Q26738576) (← links)
- Dynamic contrast enhanced CT in nodule characterization: How we review and report. (Q26739321) (← links)
- MANAGEMENT OF ENDOCRINE DISEASE: Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis (Q26743458) (← links)
- Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012 (Q26746978) (← links)
- PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology (Q26750798) (← links)
- Application of positron emission tomography (PET/CT) in diagnosis of breast cancer. Part I. Diagnosis of breast cancer prior to treatment (Q26751999) (← links)
- Quantitative Myocardial Perfusion with Dynamic Contrast-Enhanced Imaging in MRI and CT: Theoretical Models and Current Implementation (Q26752825) (← links)
- The Role of (18)F-FDG PET/CT and MRI in Assessing Pathological Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis (Q26765032) (← links)